JP2017525717A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525717A5
JP2017525717A5 JP2017510567A JP2017510567A JP2017525717A5 JP 2017525717 A5 JP2017525717 A5 JP 2017525717A5 JP 2017510567 A JP2017510567 A JP 2017510567A JP 2017510567 A JP2017510567 A JP 2017510567A JP 2017525717 A5 JP2017525717 A5 JP 2017525717A5
Authority
JP
Japan
Prior art keywords
phenyl
methanone
pyrrolidin
methyl
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017510567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525717A (ja
JP6434614B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/001570 external-priority patent/WO2016026549A1/en
Publication of JP2017525717A publication Critical patent/JP2017525717A/ja
Publication of JP2017525717A5 publication Critical patent/JP2017525717A5/ja
Application granted granted Critical
Publication of JP6434614B2 publication Critical patent/JP6434614B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017510567A 2014-08-22 2015-07-30 インダゾール Expired - Fee Related JP6434614B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14002929 2014-08-22
EP14002929.9 2014-08-22
PCT/EP2015/001570 WO2016026549A1 (en) 2014-08-22 2015-07-30 Indazoles

Publications (3)

Publication Number Publication Date
JP2017525717A JP2017525717A (ja) 2017-09-07
JP2017525717A5 true JP2017525717A5 (enExample) 2018-08-02
JP6434614B2 JP6434614B2 (ja) 2018-12-05

Family

ID=51690171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017510567A Expired - Fee Related JP6434614B2 (ja) 2014-08-22 2015-07-30 インダゾール

Country Status (9)

Country Link
US (1) US9862717B2 (enExample)
EP (1) EP3183239B1 (enExample)
JP (1) JP6434614B2 (enExample)
CN (1) CN106573932B (enExample)
AU (1) AU2015306458B2 (enExample)
CA (1) CA2958508A1 (enExample)
ES (1) ES2703851T3 (enExample)
IL (1) IL250306B (enExample)
WO (1) WO2016026549A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101731624B1 (ko) * 2014-07-01 2017-05-04 광주과학기술원 세포 리프로그래밍 유도용 조성물
JP7365332B2 (ja) * 2017-08-07 2023-10-19 ジョイント・ストック・カンパニー “バイオキャド” Cdk8/19阻害薬としての新規ヘテロ環式化合物
CN111163775B (zh) 2017-10-02 2023-07-11 勃林格殷格翰国际有限公司 作为cdk8/cdk19抑制剂的新型[1,6]萘啶化合物和衍生物
CN114585609B (zh) * 2019-06-27 2024-07-30 比奥根Ma公司 2h-吲唑衍生物及其在疾病治疗中的用途
US20240066027A1 (en) * 2020-12-03 2024-02-29 Domain Therapeutics Novel par-2 inhibitors
LT4263545T (lt) 2020-12-16 2026-07-27 Amgen Inc. Prmt5 inhibitoriai
WO2024148247A2 (en) * 2023-01-06 2024-07-11 Ajax Therapeutics, Inc. Azaindazoles as jak2 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043998B1 (en) * 1997-12-13 2007-03-07 Bristol-Myers Squibb Company USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
AU2001253540A1 (en) * 2000-04-25 2001-11-07 Bristol-Myers Squibb Company Use of 5-thio-, sulfinyl- and sulfonylpyrazolo(3,4-b)-pyridines as cyclin dependent kinase inhibitors
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
WO2011000566A2 (en) * 2009-06-30 2011-01-06 Savira Pharmaceuticals Gmbh Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
BR112012002942A2 (pt) * 2009-08-10 2015-10-13 Epitherix Llc indazóis como inibidores da trilha de sinalização de wnt/b-catenina e empregos terapêuticos destes.
MX2015007097A (es) * 2012-12-10 2015-09-29 Hoffmann La Roche Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.

Similar Documents

Publication Publication Date Title
JP2012525431A5 (enExample)
JP2010532768A5 (enExample)
JP2015537020A5 (enExample)
JP2014513704A5 (enExample)
JP2014508811A5 (enExample)
JP2013510120A5 (enExample)
JP2008535902A5 (enExample)
JP2015511609A5 (enExample)
JP2014506907A5 (enExample)
JP2011517453A5 (enExample)
JP2015522650A5 (enExample)
JP2008535903A5 (enExample)
MY145465A (en) Diaminopyrimidines as p2x3 and p2x2/3 antagonists.
JP2010509356A5 (enExample)
RU2013130253A (ru) 7-деазапуриновые регуляторы метилтрансферазы гистонов и способы их применения
JP2016516043A5 (enExample)
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
JP2017530185A5 (enExample)
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
MY139941A (en) Indole derivatives
JP2015502371A5 (enExample)
JP2016513681A5 (enExample)
JP2012518634A5 (enExample)
JP2018535235A5 (enExample)
CN103619354A (zh) 止痒剂